Mount Sinai Unveils New Comprehensive Adult Congenital Heart Disease Center
New center will help fill national gap in transition of patient care from adolescence to adulthood
The Mount Sinai Health System has launched a comprehensive Adult Congenital Heart Disease Center (ACHD Center) at Mount Sinai Heart to serve the medical and surgical needs of a growing population of adults born with congenital heart disease.
Congenital heart disease is the No. 1 birth defect in the United States, and every year nearly one out of 100 babies is born with some form of this condition. Scientific advances over the last 40 years have enabled more than 90 percent of these patients to live well into adulthood. Nationwide, 1.4 million adults are living with congenital heart disease, but 90 percent of them aren’t getting the care needed to avoid sudden and severe health issues. Mount Sinai’s ACHD Center aims to change this.
“Our center will leverage the expertise of Mount Sinai Heart, while providing seamless and expert care to patients born with cardiovascular malformations who are surviving well into adulthood and require a constellation of well-coordinated, expert services. The center will bring these services under one roof to ensure lifelong surveillance and specialized care,” says Valentin Fuster, MD, PhD, Director of Mount Sinai Heart and Physician-In-Chief of The Mount Sinai Hospital.
Ali N. Zaidi, MD, is the Director of the Mount Sinai ACHD Center. He is the only physician in New York State trained and board certified in adult congenital heart disease, adult cardiology, pediatric cardiology, internal medicine, and pediatrics and is one of a small group of physicians in the United States who has five boards. Dr. Zaidi has been practicing in the field of adult congenital heart disease for over a decade.
In addition to providing comprehensive care for adults with all forms of congenital heart disease, the Mount Sinai ACHD Center includes a dedicated Fontan Clinic which focuses on adults with single-ventricle Fontan physiology; this includes comprehensive evaluation, screening, and clinical care in a multi-disciplinary care model. Mount Sinai’s Fontan Program is one of the only programs in New York State in which ACHD specialists, hepatologists (liver specialists), nutritionists, cardiac imagers, and mental health and social workers work together in a single setting. It is one of a small group of centers in the country offering a dedicated long-term survivorship program for adults with single-ventricle Fontan physiology.
“Our adult single-ventricle survivors represent an unusual and extremely complex cohort of patients whom we believe will benefit from the care of a highly coordinated team in a clinic created explicitly for their care,” says Dr. Zaidi. “The Fontan procedure refers to the final repair in a multi-stage open-heart surgery to rebuild the heart and reroute blood flow. While single-ventricle survivors are now living longer lives as a result of improvements to Fontan palliation, it is common for them to experience long-term effects of poor blood circulation to the organ systems. To optimize their health, we have designed a program to ensure constant monitoring, expert coordination across multiple specialty lines, and a careful transition of care from adolescence to adulthood that is thoughtfully managed,” explains Dr. Zaidi.
The Mount Sinai ACHD Center will also provide dedicated reproductive health, fertility management, and high-risk pregnancy care for women with congenital heart disease; transition of care for adolescent patients with congenital heart disease; and neurocognitive care to address long-term cognitive difficulties of the adult patient with congenital heart disease. The Mount Sinai Adult Congenital Heart Disease Center will also offer state-of-the-art diagnostics including full cardiopulmonary exercise testing, right heart catheterization with vasoreactivity testing, advanced cardiovascular imaging, transcatheter congenital structural interventions, and dedicated adult congenital heart surgery. The center will work closely with the Mount Sinai Pulmonary Hypertension and the Mount Sinai Advanced Heart Failure Transplant teams in providing state-of-the-art care to ACHD patents with pulmonary hypertension, or those in need of cardiac transplantation. The Mount Sinai Adult Congenial Heart Disease Center will have access to the latest clinical trials and research in adult congential heart disease. Backed by a respected team of specialists and researchers, these clinical trials aim to further the advancement of diagnosing and treating patients with all forms of congenital heart disease and its long term symptoms..
To learn more about Mount Sinai’s ACHD Center please click on the link below:
About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty and our physicians in the top 1% of all physicians nationally by U.S. News & World Report.